Press "Enter" to skip to content

Tag: long COVID

Nouvelles études pour traiter la COVID-19 longue

The National Institutes of Health in the United States have begun a series of studies to test possible treatments for long COVID, a step eagerly awaited in the efforts of the United States to fight this mysterious disease that affects millions of people.

Comments closed

Study: 1 in 6 kids have persistent COVID symptoms for 3 months after infection

It was thought at first that the pediatric population was relatively spared from the long-term effects of COVID-19 after infection. But this changed rapidly with increasing reports and studies of pediatric patients not fully recovering from acute COVID-19.

Comments closed

Long COVID Is Disabling Kids. Why We Ignore It

Yet we may have disastrously underestimated one of the most serious sequelae: infection of the brain and nervous system. And we may have missed the neurological damage done to children and young adults who seem to have recovered from COVID-19.

Comments closed

Closing of Toronto long-COVID rehab program a failure to support patients

A Toronto-based Unity Health Rehabilitation Program for those with long COVID will be shutting down on August 31. The shuttering of the program takes one more virtual option away from those in Ontario with the condition.

Comments closed

Long COVID presents ‘unfathomable’ burden as health-care system reaches ‘boiling point’

Dr. Jennifer Hulme thought her COVID-19 infection was just “average.” She recovered in a matter of days and went back to work.

Several weeks later she was incapacitated.

“I woke up completely disabled, profoundly ill (and) completely changed from my previous self,” the Toronto emergency room doctor said.

Comments closed

The Pandemic Has Faded From View. But Many Educators Still Have Long COVID

More than three years after the COVID-19 pandemic shut down schools, one in 20 K-12 educators believe they have long COVID. Another 14 percent think or know they previously had it but eventually recovered.

Comments closed

Millions of Patients Do Not Have Full Recovery of Smell or Taste Senses After COVID Infection, Study Finds

Retrospective analysis of national data led by investigators from Mass Eye and Ear estimates that over 20 million COVID patients experienced loss of smell or taste in 2021, with a large portion of patients never fully recovering these senses.

Comments closed

Millions of patients do not have full recovery of smell or taste senses after COVID infection, study finds

A retrospective study by researchers at Massachusetts Eye and Ear, a member of the Mass General Brigham healthcare system, investigated the loss of olfactory and gustatory senses and estimated that about a quarter of Americans who had COVID-19 reported only partial or no recovery of taste or smell.

Comments closed

Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds

Metformin—a cheap, safe, and widely available diabetes drug—could reduce the incidence of long covid if given during the acute phase of covid-19, a new study indicates.

A two week course of metformin given within three days of testing positive for SARS-CoV-2 led to 40% fewer long covid diagnoses over the following 10 months compared with people who had taken placebo, according to a randomised controlled trial.

Leave a comment

Researchers discover that COVID-19 can cause brain cells to fuse

Researchers at The University of Queensland have discovered that SARS-CoV-2 and other viruses can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.

Comments closed

Could fused neurons explain COVID-19’s ‘brain fog’?

Researchers have demonstrated that a SARS-CoV-2 infection can induce brain cells to fuse together, with severe impacts on the functioning of neurons. Neurons may fuse together with other neurons or glia, and larger multicellular syncytia may be formed. The fusion of neurons may be one of the causes of the cognitive issues associated with COVID-19.

Comments closed

CAMH study confirms ongoing brain inflammation associated with long COVID

A new Centre for Addiction and Mental Health (CAMH) study found elevated levels of inflammation in the brains of patients who report persistent symptoms of long COVID.

Using advanced brain scanning with positron emission tomography (PET), the researchers found elevated levels of the protein TSPO, a brain marker of inflammation, in patients with onset of depression within several months after a COVID-19 infection.

Comments closed